Ong S, Chua Z, Yuen J, Chiang J, Zewen Z, Ngeow J
Fam Cancer. 2025; 24(1):25.
PMID: 40011264
DOI: 10.1007/s10689-025-00450-2.
Tiller J, Nowak K, Boughtwood T, Otlowski M
BioTech (Basel). 2023; 12(2).
PMID: 37366793
PMC: 10296322.
DOI: 10.3390/biotech12020045.
Tiller J, Stott A, Finlay K, Boughtwood T, Madelli E, Horton A
Eur J Hum Genet. 2023; 32(1):98-108.
PMID: 37280361
PMC: 10242214.
DOI: 10.1038/s41431-023-01395-9.
Sun L, Wolska A, Amar M, Zubiran R, Remaley A
J Clin Endocrinol Metab. 2023; 108(9):2424-2434.
PMID: 36929838
PMC: 10438872.
DOI: 10.1210/clinem/dgad153.
Martucci J, Prado Y, Rope A, Weinmann S, White L, Zepp J
J Law Med Ethics. 2023; 50(4):818-832.
PMID: 36883408
PMC: 10009393.
DOI: 10.1017/jme.2023.23.
First genetic characterization of Xeroderma pigmentosum in Libya: High frequency of XP-C founder mutation.
Khalat N, Messaoud O, Ben Rekaya M, Chargui M, Zghal M, Zendah B
Mol Genet Genomic Med. 2023; 11(6):e2158.
PMID: 36812379
PMC: 10265042.
DOI: 10.1002/mgg3.2158.
A pragmatic clinical trial of cascade testing for familial hypercholesterolemia.
Miller A, Bangash H, Smith C, Wood-Wentz C, Bailey K, Kullo I
Genet Med. 2022; 24(12):2535-2543.
PMID: 36173399
PMC: 9944844.
DOI: 10.1016/j.gim.2022.08.026.
Environmental scan of family chart linking for genetic cascade screening in a U.S. integrated health system.
Haas C, Ralston J, Fullerton S, Scrol A, Henrikson N
Front Genet. 2022; 13:886650.
PMID: 36035175
PMC: 9403414.
DOI: 10.3389/fgene.2022.886650.
Detecting Familial hypercholesterolemia in children and adolescents: potential and challenges.
Banderali G, Capra M, Biasucci G, Stracquadaino R, Viggiano C, Pederiva C
Ital J Pediatr. 2022; 48(1):115.
PMID: 35840982
PMC: 9287900.
DOI: 10.1186/s13052-022-01257-y.
The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives.
Schmidlen T, Bristow S, Hatchell K, Esplin E, Nussbaum R, Haverfield E
Front Genet. 2022; 13:867226.
PMID: 35783293
PMC: 9243226.
DOI: 10.3389/fgene.2022.867226.
Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study.
Jones L, Walters N, Brangan A, Ahmed C, Gatusky M, Campbell-Salome G
J Pers Med. 2021; 11(6).
PMID: 34205662
PMC: 8234213.
DOI: 10.3390/jpm11060587.
Novel drug candidates targeting Alzheimer's disease: ethical challenges with identifying the relevant patient population.
Gustavsson E, Raaschou P, Larfars G, Sandman L, Juth N
J Med Ethics. 2021; 47(9):608-614.
PMID: 34117127
PMC: 8394767.
DOI: 10.1136/medethics-2021-107304.
Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy.
Roosan D, Hwang A, Roosan M
Pharmacogenomics J. 2020; 21(1):1-7.
PMID: 32843688
PMC: 7840503.
DOI: 10.1038/s41397-020-00182-9.
Catecholaminergic polymorphic ventricular tachycardia due to RyR2 mutation: recreational cycling as a trigger of lethal arrhythmias.
Gallegos-Cortez A, Alonso-Ortiz N, Antunez-Arguellez E, Villarreal-Molina T, Totomoch-Serra A, Iturralde-Torres P
Arch Med Sci. 2020; 16(2):466-470.
PMID: 32190159
PMC: 7069429.
DOI: 10.5114/aoms.2019.89691.
Cascade Testing for Fragile X Syndrome in a Rural Setting in Cameroon (Sub-Saharan Africa).
Kamga K, Nguefack S, Minka K, Wonkam Tingang E, Esterhuizen A, Munung S
Genes (Basel). 2020; 11(2).
PMID: 32012997
PMC: 7074341.
DOI: 10.3390/genes11020136.
Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.
Frey M, Kahn R, Chapman-Davis E, Tubito F, Pires M, Christos P
J Clin Oncol. 2020; 38(13):1389-1397.
PMID: 31922918
PMC: 7193751.
DOI: 10.1200/JCO.19.02005.
A pediatric perspective on genomics and prevention in the twenty-first century.
Chaudhari B, Manickam K, McBride K
Pediatr Res. 2019; 87(2):338-344.
PMID: 31578042
DOI: 10.1038/s41390-019-0597-z.
The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication.
Harris S, Cirino A, Carr C, Tafessu H, Parmar S, Greenberg J
Mol Genet Genomic Med. 2019; 7(11):e940.
PMID: 31482667
PMC: 6825857.
DOI: 10.1002/mgg3.940.
Stakeholder Views on Active Cascade Screening for Familial Hypercholesterolemia.
van El C, Baccolini V, Piko P, Cornel M
Healthcare (Basel). 2018; 6(3).
PMID: 30200297
PMC: 6163326.
DOI: 10.3390/healthcare6030108.
Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia.
Silva P, Jannes C, Oliveira T, Gomez Gomez L, Krieger J, Santos R
Arq Bras Cardiol. 2018; 111(4):578-584.
PMID: 30156605
PMC: 6199512.
DOI: 10.5935/abc.20180156.